- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05781971
Effect of Nutritional Support and Early Rehabilitation on Sepsis (NUSPOTER)
June 14, 2024 updated by: Yao Wei,MD, Jinling Hospital, China
Department of Intensive Care Medicine, The First Affiliated Hospital of Soochow University
Sepsis is a syndrome of life-threatening organ dysfunction caused by a dysregulated host response to infection.Acute catabolic response in critically ill patients struck by sepsis, manifested by massive protein breakdown in a short time.This pathology frequently leads to prolonged hospitalization and mechanical ventilation, increased mortality, and reduced quality of survival.It is uncertainty whether sepsis patients in ICU can benefit from high protein intake combined with early exercise.
Even though the combination has been shown to be beneficial in other populations.In the present study, the investigator will evaluate the effects of a combination of high protein targets combined with early rehabilitation in sepsis patients in ICU.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Existing research results confirm that high target protein support can reduce the mortality of sepsis patients.
Early bedside rehabilitation has a good effect on cognitive function after ICU.
This study combined high-protein nutritional support with bedside rehabilitation to improve the quality of life in patients with sepsis after ICU.
Study Type
Interventional
Enrollment (Estimated)
1600
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Standard
- Patients with sepsis
- Patients aged 18-70 years
- Time of admission ≤48 h
- Non-terminal condition
Exclusion Standard
- Severe acute kidney injury
- Severe chronic liver disease (MELD score ≥20) or acute hepatic failure
- Protein allergy
- Pregnancy and lactation
- BMI≥30 kg/m²
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: high protein + early bedside rehabilitation
|
Patients in high-protein group will be given a target protein amount of 2.0 g/kg/d.
Standard enteral nutrition is the first choice,the remaining target value will be met by intravenous amino acid infusion.
In this trial, the investigator will provide early rehabilitation treatment such as respiratory training, bicycle training, and medium frequency electrical stimulation to patients.
|
|
Active Comparator: high protein alone
|
Patients in high-protein group will be given a target protein amount of 2.0 g/kg/d.
Standard enteral nutrition is the first choice,the remaining target value will be met by intravenous amino acid infusion.
|
|
Placebo Comparator: standard protein + early bedside
standard protein and rehabilitation
|
In this trial, the investigator will provide early rehabilitation treatment such as respiratory training, bicycle training, and medium frequency electrical stimulation to patients.
The investigator set a protein target of 1.2 g/Kg/d for the standard protein group, which will be supplied enterally or parenterally.
|
|
Sham Comparator: standard protein
only standard protein
|
The investigator set a protein target of 1.2 g/Kg/d for the standard protein group, which will be supplied enterally or parenterally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Mortality
Time Frame: Day 90
|
Chart review
|
Day 90
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutrition related indicators
Time Frame: Hospital discharge
|
Chart review
|
Hospital discharge
|
|
Physical functioning
Time Frame: Hospital discharge
|
Grip dynamometer
|
Hospital discharge
|
|
Prognostic factor
Time Frame: Hospital discharge
|
Chart review
|
Hospital discharge
|
|
Health-related quality of life
Time Frame: Day 90
|
SF-36 and EQ-5D-5L
|
Day 90
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
May 1, 2026
Study Registration Dates
First Submitted
February 1, 2023
First Submitted That Met QC Criteria
March 12, 2023
First Posted (Actual)
March 23, 2023
Study Record Updates
Last Update Posted (Actual)
June 17, 2024
Last Update Submitted That Met QC Criteria
June 14, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- NUSPOTER
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Life Quality
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
Universidad de ExtremaduraActive, not recruitingLife Style, Healthy | Life Style Modification | Life Quality | Physical ActivitiesSpain
-
Ataturk UniversityRecruitingLife Quality | Symptom ManagementTurkey
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on high protein
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Purdue UniversityCompletedObesity | Dietary Modification | Lack of Satiety | Memory DeficitsUnited States
-
Wageningen UniversityTop Institute Food and NutritionCompletedIdentify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.Netherlands
-
Rio de Janeiro State UniversityRio de Janeiro State Research Supporting Foundation (FAPERJ)Completed
-
Erik Ramirez LopezCompletedWeight Loss | Body CompositionMexico
-
University of California, Los AngelesNational Institutes of Health (NIH)Completed
-
Purdue UniversityCompletedBlood Pressure | Cardiovascular Risk FactorUnited States
-
McMaster UniversityCompleted
-
Fresenius KabiCompleted